MXPA05011707A - Dihidroquinazolinas sustituidas con propiedades antivirales. - Google Patents

Dihidroquinazolinas sustituidas con propiedades antivirales.

Info

Publication number
MXPA05011707A
MXPA05011707A MXPA05011707A MXPA05011707A MXPA05011707A MX PA05011707 A MXPA05011707 A MX PA05011707A MX PA05011707 A MXPA05011707 A MX PA05011707A MX PA05011707 A MXPA05011707 A MX PA05011707A MX PA05011707 A MXPA05011707 A MX PA05011707A
Authority
MX
Mexico
Prior art keywords
dihydrochinazolines
substituted
antiviral properties
antiviral
treating
Prior art date
Application number
MXPA05011707A
Other languages
English (en)
Inventor
Peter Nell
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of MXPA05011707A publication Critical patent/MXPA05011707A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

La invencion se refiere a dihidroquinazolinas sustituidas de formula (I) y a procedimientos para su preparacion asi como a su uso para la preparacion de medicamentos para el tratamiento y/o la profilaxis de enfermedades, especialmente para el uso como agente antiviral, especialmente contra citomegalovirus.
MXPA05011707A 2003-05-02 2004-04-17 Dihidroquinazolinas sustituidas con propiedades antivirales. MXPA05011707A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10319612A DE10319612A1 (de) 2003-05-02 2003-05-02 Substituierte Dihydrochinazoline
PCT/EP2004/004103 WO2004096778A1 (de) 2003-05-02 2004-04-17 Substituierte dihydrochinazoline mit antiviralen eigenschaften

Publications (1)

Publication Number Publication Date
MXPA05011707A true MXPA05011707A (es) 2006-02-13

Family

ID=33305099

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011707A MXPA05011707A (es) 2003-05-02 2004-04-17 Dihidroquinazolinas sustituidas con propiedades antivirales.

Country Status (39)

Country Link
US (4) US7196086B2 (es)
EP (1) EP1622880B3 (es)
JP (1) JP4733631B2 (es)
KR (1) KR100927063B1 (es)
CN (1) CN100393706C (es)
AR (1) AR044078A1 (es)
AT (1) ATE355280T1 (es)
AU (1) AU2004233978B2 (es)
BR (1) BRPI0410029B8 (es)
CA (1) CA2524069C (es)
CL (1) CL2004000930A1 (es)
CO (1) CO5700764A2 (es)
CY (2) CY1106476T1 (es)
DE (2) DE10319612A1 (es)
DK (1) DK1622880T6 (es)
EC (1) ECSP056138A (es)
EG (1) EG25273A (es)
ES (1) ES2284007T7 (es)
FR (1) FR18C1029I2 (es)
HK (1) HK1092463A1 (es)
HN (1) HN2004000146A (es)
HU (2) HUS1800018I1 (es)
IL (1) IL171513A (es)
MA (1) MA27794A1 (es)
MX (1) MXPA05011707A (es)
MY (1) MY144616A (es)
NL (1) NL300933I2 (es)
NO (2) NO333265B3 (es)
NZ (1) NZ543317A (es)
PE (1) PE20050145A1 (es)
PL (1) PL1622880T6 (es)
PT (1) PT1622880E (es)
RU (1) RU2360912C2 (es)
SI (1) SI1622880T1 (es)
TW (1) TWI335912B (es)
UA (1) UA82519C2 (es)
UY (1) UY28294A1 (es)
WO (1) WO2004096778A1 (es)
ZA (1) ZA200508710B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE10305785A1 (de) * 2003-02-12 2004-08-26 Bayer Healthcare Ag Dihydrochinazoline
DE10320780A1 (de) * 2003-05-09 2005-01-20 Bayer Healthcare Ag Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) 2003-11-11 2005-06-09 Bayer Healthcare Ag Substituierte Dihydrochinazoline II
DE102004022672A1 (de) * 2004-05-07 2005-11-24 Bayer Healthcare Ag Substituierte Azachinazoline
DE102005027517A1 (de) * 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
DE102012101659A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101673A1 (de) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats
BR112015031979B1 (pt) * 2013-06-19 2022-05-24 Aicuris Anti-Infective Cures Gmbh Letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir
WO2015088931A1 (en) * 2013-12-12 2015-06-18 Merck Sharp & Dohme Corp. Process for making substituted quinazoline compounds
WO2017091453A1 (en) * 2015-11-24 2017-06-01 Merck Sharp & Dohme Corp. Novel processes for making substituted quinazoline compounds using hydrogen bonding catalysts
WO2018028556A1 (zh) * 2016-08-08 2018-02-15 南京明德新药研发股份有限公司 抗hcmv病毒化合物
AU2019218150B2 (en) * 2018-02-08 2021-05-13 Phaeno Therapeutics Co., Ltd. Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor
EP3527209A1 (en) * 2018-02-16 2019-08-21 UCB Biopharma SPRL Pharmaceutical 6,5 heterobicyclic ring derivatives
AU2019339777B2 (en) 2018-09-12 2022-09-01 Novartis Ag Antiviral pyridopyrazinedione compounds
JP7417715B2 (ja) 2019-09-26 2024-01-18 ノバルティス アーゲー 抗ウイルスピラゾロピリジノン化合物
UY39096A (es) 2020-02-27 2021-09-30 Aic246 Gmbh & Co Kg Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato
UY39098A (es) 2020-02-27 2021-09-30 Aic246 Gmbh & Co Kg 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio monohidrato, su preparación y uso
UY39095A (es) 2020-02-27 2021-09-30 Aic246 Gmbh & Co Kg Composiciones farmacéuticas que comprenden acetato de 2- [(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il] e iones de sodio
UY39099A (es) 2020-02-27 2021-08-31 Aic246 Gmbh & Co Kg 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] acetato de sodio y composiciones farmacéuticas del mismo
AR121437A1 (es) 2020-02-27 2022-06-08 Aic246 Gmbh & Co Kg Sal de potasio del ácido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acético
EP3906929A1 (en) 2020-05-08 2021-11-10 AiCuris GmbH & Co. KG Letermovir for use in the prevention and the treatment of coronavirus infections
US20230312485A1 (en) 2020-08-17 2023-10-05 Lupin Limited A precipitation process for amorphous letermovir
CN115403528A (zh) * 2021-05-27 2022-11-29 南京正大天晴制药有限公司 无定形3,4-二氢喹唑啉衍生物的制备方法
CN114031560B (zh) * 2021-11-16 2022-10-04 山东诚创蓝海医药科技有限公司 一种来特莫韦钠盐的制备方法
AR128035A1 (es) 2021-12-21 2024-03-20 Aic246 Ag & Co Kg Composiciones farmacéuticas que comprenden acetato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il] e iones de potasio
WO2023185597A1 (zh) * 2022-04-01 2023-10-05 上海迪赛诺化学制药有限公司 莱特莫韦中间体及其制备方法
CN115322157B (zh) * 2022-06-02 2023-12-05 浙江车头制药股份有限公司 来特莫韦中间体化合物及其制备方法和应用
CN117229223A (zh) * 2022-06-08 2023-12-15 苏州远智医药科技有限公司 一种杂环衍生物及其药物组合物、应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4320347A1 (de) 1993-06-19 1994-12-22 Boehringer Mannheim Gmbh Quinazolin-Derivate und diese enthaltende Arzneimittel
US5854245A (en) 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
NZ506417A (en) 1998-02-17 2003-05-30 Tularik Inc Anti-viral pyrimidine derivatives
CN1347411A (zh) 1999-04-19 2002-05-01 盐野义制药株式会社 含有噁二唑环的磺酰胺衍生物
DE19930075A1 (de) 1999-06-30 2001-01-04 Bayer Ag Neue Amino- und Amidosulfonamide als antivirale Mittel
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
EP1325008B1 (en) 2000-07-31 2005-10-05 F. Hoffmann-La Roche Ag Piperazine derivatives
EP1201765A3 (en) * 2000-10-16 2003-08-27 Axxima Pharmaceuticals Aktiengesellschaft Cellular kinases involved in cytomegalovirus infection and their inhibition
US7115612B2 (en) 2001-04-19 2006-10-03 Bayer Aktiengesellschaft Arylsulfonamides as antiviral agents
DE10138578A1 (de) 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide
DE10251914A1 (de) 2002-11-08 2004-05-19 Bayer Ag Substituierte Chinazoline
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE10305785A1 (de) * 2003-02-12 2004-08-26 Bayer Healthcare Ag Dihydrochinazoline
DE10320780A1 (de) 2003-05-09 2005-01-20 Bayer Healthcare Ag Heterocyclyl-substituierte Dihydrochinazoline
DE10352499A1 (de) 2003-11-11 2005-06-09 Bayer Healthcare Ag Substituierte Dihydrochinazoline II
KR100610731B1 (ko) 2004-02-24 2006-08-09 한국과학기술연구원 Ｔ-형 칼슘 채널 차단제로서 유용한 ３,４-디히드로퀴나졸린유도체 및 그의 제조 방법
DE102004022672A1 (de) 2004-05-07 2005-11-24 Bayer Healthcare Ag Substituierte Azachinazoline
KR20080009048A (ko) * 2005-01-25 2008-01-24 프롤렉시스 파마슈티칼스, 인크. 항종양제로서 퀴녹살린 유도체
DE102005027517A1 (de) 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
ATE449097T1 (de) 2005-07-21 2009-12-15 Hoffmann La Roche Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
DE102006009928A1 (de) 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
DE102012101659A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
DE102012101673A1 (de) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salze eines Dihydrochinazolinderivats
BR112015031979B1 (pt) * 2013-06-19 2022-05-24 Aicuris Anti-Infective Cures Gmbh Letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir

Also Published As

Publication number Publication date
ES2284007T7 (es) 2018-06-20
ES2284007T3 (es) 2007-11-01
NO333265B1 (no) 2013-04-22
EP1622880A1 (de) 2006-02-08
CA2524069C (en) 2011-11-08
BRPI0410029B1 (pt) 2019-12-31
WO2004096778A1 (de) 2004-11-11
RU2360912C2 (ru) 2009-07-10
EG25273A (en) 2011-12-04
USRE46791E1 (en) 2018-04-17
US20050065160A1 (en) 2005-03-24
CN100393706C (zh) 2008-06-11
KR100927063B1 (ko) 2009-11-13
NO333265B3 (no) 2019-06-03
PT1622880E (pt) 2007-06-04
EP1622880B1 (de) 2007-02-28
USRE49698E1 (en) 2023-10-17
CA2524069A1 (en) 2004-11-11
ECSP056138A (es) 2006-04-19
KR20060009883A (ko) 2006-02-01
AU2004233978B2 (en) 2010-02-11
TW200510343A (en) 2005-03-16
US8513255B2 (en) 2013-08-20
NZ543317A (en) 2008-05-30
EP1622880B3 (de) 2018-05-23
DE502004003052D1 (de) 2007-04-12
DK1622880T3 (da) 2007-06-25
NO20055649D0 (no) 2005-11-30
IL171513A (en) 2011-11-30
PL1622880T6 (pl) 2018-08-31
CY1106476T1 (el) 2012-01-25
MY144616A (en) 2011-10-14
JP2006525249A (ja) 2006-11-09
AR044078A1 (es) 2005-08-24
TWI335912B (en) 2011-01-11
HUS1800028I1 (hu) 2018-07-30
RU2005137276A (ru) 2006-07-27
CY2018019I2 (el) 2018-12-12
PL1622880T3 (pl) 2007-08-31
BRPI0410029B8 (pt) 2021-06-15
ZA200508710B (en) 2006-12-27
BRPI0410029A (pt) 2006-04-25
NO2018022I1 (no) 2018-07-04
CL2004000930A1 (es) 2005-03-18
DE10319612A1 (de) 2004-11-18
CN1784390A (zh) 2006-06-07
ATE355280T1 (de) 2006-03-15
AU2004233978A1 (en) 2004-11-11
NL300933I2 (nl) 2018-04-26
HK1092463A1 (en) 2007-02-09
FR18C1029I1 (es) 2018-08-17
FR18C1029I2 (fr) 2020-07-17
CO5700764A2 (es) 2006-11-30
PE20050145A1 (es) 2005-05-22
JP4733631B2 (ja) 2011-07-27
DK1622880T6 (da) 2018-06-18
CY2018019I1 (el) 2018-12-12
HUS1800018I1 (hu) 2018-05-28
HN2004000146A (es) 2008-06-24
MA27794A1 (fr) 2006-03-01
UY28294A1 (es) 2004-11-30
US20070191387A1 (en) 2007-08-16
US7196086B2 (en) 2007-03-27
NO20055649L (no) 2006-01-31
SI1622880T1 (sl) 2007-08-31
UA82519C2 (uk) 2008-04-25

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
WO2005063734A3 (de) Substituierte thiophene
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
UA85559C2 (en) Aminobenzophenone compounds
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
HK1093729A1 (en) Substituted quinolones
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2006089664A3 (de) Heterocyclylamid-substituierte imidazole
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
PT1606288E (pt) Derivados de benzenossulfonamida, processo para a sua preparação e a sua utilização para tratamento da dor
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MY151590A (en) Substituted quinolones iii
MXPA06000507A (es) Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiovasculares.
ATE553088T1 (de) Substituierte chinolone ii

Legal Events

Date Code Title Description
GB Transfer or rights
FG Grant or registration